Our Latest Stories

Social Impact
February 4, 2025
Childhood Cancer R&D Program: Developing and Accelerating Novel Therapies for Children With Cancer

United by Purpose
Each of us plays a unique role in bringing our purpose to life.
About Us

Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
83
Compounds in clinical development
26
Clinical trials in phase 3

Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.
Our Latest Press Releases
February 7, 2025
Press Release: Execution of a share buyback agreement for up to €2 billion
February 6, 2025
Media Update: AAAAI: new data reinforce Sanofi’s leadership in immunology and scientific innovation for patients
February 3, 2025
Press Release: Sanofi announces buy back of shares from L’Oréal
January 31, 2025
Press Release: Sarclisa is the first anti-CD38 treatment in combination with standard-of-care VRd approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant